The results increase “my confidence that this approach has merit,” Lauren Sansing says. More trials are on the way.

New research provides further evidence that thrombolysis benefits select patients with acute ischemic stroke up to 24 hours after symptom onset.

In any case, there was no mortality signal associated with alteplase administered up to 24 hours after a stroke in HOPE.

Alteplase improves stroke recovery by over 50% when given up to 24 hours after symptom onset, offering hope for patients with ...